E3泛素连接酶wsb1介导的DIO2泛素化修饰通过阻断甲状腺激素信号通路促进结直肠癌的发生和转移。

IF 5.6 2区 医学 Q1 PHARMACOLOGY & PHARMACY
Peng Zhai, Qiang Li, Yongjun Jiang, Huaguo Zhang, Chungen Xing
{"title":"E3泛素连接酶wsb1介导的DIO2泛素化修饰通过阻断甲状腺激素信号通路促进结直肠癌的发生和转移。","authors":"Peng Zhai, Qiang Li, Yongjun Jiang, Huaguo Zhang, Chungen Xing","doi":"10.1016/j.bcp.2025.117433","DOIUrl":null,"url":null,"abstract":"<p><p>Metastasis represents the major cause of colorectal cancer (CRC)-related mortality. Here, we sought to examine the mechanism of WD repeat and SOCS box-containing protein 1 (WSB1), an E3 ubiquitin ligase, in CRC liver metastasis (LM). An orthotopic implantation CRC model was constructed to analyze the differences in gene expression within cecum xenograft tumors (CXTs) and LMs. WSB1 was significantly higher expressed within the LM of nude mice than CXT, whereas type II iodothyronine deiodinase (DIO2) was higher in CXT. WSB1 knockdown hampered LM in CRC with orthotopic tumors, which was reversed by DIO2 knockdown. WSB1 degraded DIO2 by ubiquitination modification. The roles of the WSB1/DIO2/T3/TRβ1 axis in CRC cell proliferation, migration, invasion, and stemness were also probed. Treatment of SW620 cells with knockdown of DIO2 in combination with T3 reversed the malignant progression of CRC in vitro and in vivo caused by knockdown of DIO2, but the intervention of sh-TRβ1 in turn reversed the therapeutic benefit of T3 on malignant progression of CRC. Taken together, our results identify the DIO2 degradation by WSB1 and subsequent impairment of T3/TRβ1 signaling as mechanisms leading to LM in CRC. These findings can inform therapeutic interventions for this event.</p>","PeriodicalId":8806,"journal":{"name":"Biochemical pharmacology","volume":" ","pages":"117433"},"PeriodicalIF":5.6000,"publicationDate":"2025-10-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"E3 ubiquitin ligase WSB1-mediated ubiquitination modification of DIO2 promotes colorectal cancer stemness and metastasis by blocking thyroid hormone signaling.\",\"authors\":\"Peng Zhai, Qiang Li, Yongjun Jiang, Huaguo Zhang, Chungen Xing\",\"doi\":\"10.1016/j.bcp.2025.117433\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Metastasis represents the major cause of colorectal cancer (CRC)-related mortality. Here, we sought to examine the mechanism of WD repeat and SOCS box-containing protein 1 (WSB1), an E3 ubiquitin ligase, in CRC liver metastasis (LM). An orthotopic implantation CRC model was constructed to analyze the differences in gene expression within cecum xenograft tumors (CXTs) and LMs. WSB1 was significantly higher expressed within the LM of nude mice than CXT, whereas type II iodothyronine deiodinase (DIO2) was higher in CXT. WSB1 knockdown hampered LM in CRC with orthotopic tumors, which was reversed by DIO2 knockdown. WSB1 degraded DIO2 by ubiquitination modification. The roles of the WSB1/DIO2/T3/TRβ1 axis in CRC cell proliferation, migration, invasion, and stemness were also probed. Treatment of SW620 cells with knockdown of DIO2 in combination with T3 reversed the malignant progression of CRC in vitro and in vivo caused by knockdown of DIO2, but the intervention of sh-TRβ1 in turn reversed the therapeutic benefit of T3 on malignant progression of CRC. Taken together, our results identify the DIO2 degradation by WSB1 and subsequent impairment of T3/TRβ1 signaling as mechanisms leading to LM in CRC. These findings can inform therapeutic interventions for this event.</p>\",\"PeriodicalId\":8806,\"journal\":{\"name\":\"Biochemical pharmacology\",\"volume\":\" \",\"pages\":\"117433\"},\"PeriodicalIF\":5.6000,\"publicationDate\":\"2025-10-17\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Biochemical pharmacology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1016/j.bcp.2025.117433\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"PHARMACOLOGY & PHARMACY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Biochemical pharmacology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.bcp.2025.117433","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

摘要

转移是结直肠癌(CRC)相关死亡的主要原因。在这里,我们试图研究WD重复和含SOCS盒蛋白1 (WSB1),一种E3泛素连接酶,在结直肠癌肝转移(LM)中的机制。构建原位植入CRC模型,分析盲肠异种移植肿瘤(CXTs)和LMs中基因表达的差异。WSB1在裸鼠LM中的表达明显高于对照组,而II型碘甲状腺原氨酸脱碘酶(DIO2)在对照组中的表达明显高于对照组。WSB1敲低可抑制CRC原位肿瘤患者的LM,而DIO2敲低可逆转这一过程。WSB1通过泛素化修饰降解二氧化氧。并探讨了WSB1/DIO2/T3/TRβ1轴在结直肠癌细胞增殖、迁移、侵袭和干性中的作用。在体外和体内,敲低DIO2联合T3治疗SW620细胞逆转了由敲低DIO2引起的CRC恶性进展,但sh-TRβ1的干预反过来逆转了T3对CRC恶性进展的治疗效果。综上所述,我们的研究结果确定了WSB1对DIO2的降解以及随后的T3/TRβ1信号的损伤是导致CRC发生LM的机制。这些发现可以为该事件的治疗干预提供信息。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
E3 ubiquitin ligase WSB1-mediated ubiquitination modification of DIO2 promotes colorectal cancer stemness and metastasis by blocking thyroid hormone signaling.

Metastasis represents the major cause of colorectal cancer (CRC)-related mortality. Here, we sought to examine the mechanism of WD repeat and SOCS box-containing protein 1 (WSB1), an E3 ubiquitin ligase, in CRC liver metastasis (LM). An orthotopic implantation CRC model was constructed to analyze the differences in gene expression within cecum xenograft tumors (CXTs) and LMs. WSB1 was significantly higher expressed within the LM of nude mice than CXT, whereas type II iodothyronine deiodinase (DIO2) was higher in CXT. WSB1 knockdown hampered LM in CRC with orthotopic tumors, which was reversed by DIO2 knockdown. WSB1 degraded DIO2 by ubiquitination modification. The roles of the WSB1/DIO2/T3/TRβ1 axis in CRC cell proliferation, migration, invasion, and stemness were also probed. Treatment of SW620 cells with knockdown of DIO2 in combination with T3 reversed the malignant progression of CRC in vitro and in vivo caused by knockdown of DIO2, but the intervention of sh-TRβ1 in turn reversed the therapeutic benefit of T3 on malignant progression of CRC. Taken together, our results identify the DIO2 degradation by WSB1 and subsequent impairment of T3/TRβ1 signaling as mechanisms leading to LM in CRC. These findings can inform therapeutic interventions for this event.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Biochemical pharmacology
Biochemical pharmacology 医学-药学
CiteScore
10.30
自引率
1.70%
发文量
420
审稿时长
17 days
期刊介绍: Biochemical Pharmacology publishes original research findings, Commentaries and review articles related to the elucidation of cellular and tissue function(s) at the biochemical and molecular levels, the modification of cellular phenotype(s) by genetic, transcriptional/translational or drug/compound-induced modifications, as well as the pharmacodynamics and pharmacokinetics of xenobiotics and drugs, the latter including both small molecules and biologics. The journal''s target audience includes scientists engaged in the identification and study of the mechanisms of action of xenobiotics, biologics and drugs and in the drug discovery and development process. All areas of cellular biology and cellular, tissue/organ and whole animal pharmacology fall within the scope of the journal. Drug classes covered include anti-infectives, anti-inflammatory agents, chemotherapeutics, cardiovascular, endocrinological, immunological, metabolic, neurological and psychiatric drugs, as well as research on drug metabolism and kinetics. While medicinal chemistry is a topic of complimentary interest, manuscripts in this area must contain sufficient biological data to characterize pharmacologically the compounds reported. Submissions describing work focused predominately on chemical synthesis and molecular modeling will not be considered for review. While particular emphasis is placed on reporting the results of molecular and biochemical studies, research involving the use of tissue and animal models of human pathophysiology and toxicology is of interest to the extent that it helps define drug mechanisms of action, safety and efficacy.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信